Comments

Aerovate Therapeutics

Q: What sector and industry does Aerovate Therapeutics (AVTE) operate in?

Aerovate Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

AVTENASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$2.60

0.041.56%

At close: -

$2.49

-0.11-4.23%

After Hours: Dec 23, 4:43 PM EDT

Aerovate Therapeutics (AVTE) Forecast

News Earnings Aerovate Therapeutics (AVTE) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Aerovate Therapeutics (NASDAQ:AVTE) Stock Quotes, Forecast and News Summary

Aerovate Therapeutics Stock (NASDAQ: AVTE) stock price, news, charts, stock research, profile.

Open	$2.56
Close	$2.60
Volume / Avg.	75.29K / 764.92K
Day Range	$2.54 - $2.61
52 Wk Range	1.25 - 32.42
Market Cap	$71.90M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	50
Short Interest	16.37%
Days to Cover	12.05

Recent News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

1.9

Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.56
Close	$2.60
Volume / Avg.	75.29K / 764.92K
Day Range	$2.54 - $2.61
52 Wk Range	1.25 - 32.42
Market Cap	$71.90M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	50
Short Interest	16.37%
Days to Cover	12.05

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Aerovate Therapeutics (AVTE) stock?

You can purchase shares of Aerovate Therapeutics (NASDAQ:AVTE) through any online brokerage.

View our list of the best stock brokerages

Who are Aerovate Therapeutics (AVTE) competitors?

Other companies in Aerovate Therapeutics’s space includes: Skye Bioscience (NASDAQ:SKYE), bluebird bio (NASDAQ:BLUE), Immuneering (NASDAQ:IMRX), Armata Pharmaceuticals (AMEX:ARMP) and Citius Oncology (NASDAQ:CTOR).

What is the forecast, or price target, for Aerovate Therapeutics (AVTE) stock?

Aerovate Therapeutics has a consensus price target of $11.75.

What is the current price for Aerovate Therapeutics (AVTE)?

The stock price for Aerovate Therapeutics (NASDAQ: AVTE) is $2.4901 last updated December 23, 2024 at 4:43 PM EST.

Does Aerovate Therapeutics (AVTE) pay a dividend?

There are no upcoming dividends for Aerovate Therapeutics.

When is Aerovate Therapeutics (NASDAQ:AVTE) reporting earnings?

Aerovate Therapeutics’s Q4 earnings are confirmed for Monday, March 24, 2025.

Is Aerovate Therapeutics (AVTE) going to split?

There is no upcoming split for Aerovate Therapeutics.

What sector and industry does Aerovate Therapeutics (AVTE) operate in?

Aerovate Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.